目的：研究抑肽酶联合生长抑素治疗重症急性胰腺炎的临床效果。方法选取本院104例重症急性胰腺炎患者为研究对象，抽签随机分为研究组（54例）与对照组（50例），两组均采取生长抑素治疗，研究组另采取抑肽酶治疗，比较两组治疗1疗程后临床疗效及腹痛缓解时间、腹胀缓解时间、白细胞恢复时间、血淀粉酶恢复时间及住院时间，并观察两组并发症发生率。结果研究组治疗总有效率为92.6%显著高于78.0%，对比差异显著（P0.05）。结论抑肽酶联合生长抑素治疗重症急性胰腺炎效果显著，可缩短康复时间，且安全性较高，具有较高的临床应用价值。%Objective To study the clinical effect of the application of aprotinin combined with somatostatin in the treatment of severe acute pancreatitis.Methods 104 cases of patients with severe acute pancreatitis, treated in our hospital, were selected as the research object, and were randomly divided into study group (54 cases) and control group (50 cases). Two groups were treated with somatostatin, but study group was also treated with aprotinin. The clinical curative effect and the abdominal pain relief time, remission time of abdominal distension, white blood cell recovery time, blood amylase recovery time and hospitalization time of the two groups were compared after 1 course of treatment , and the incidence of complications of the two groups were also observed.Results The total efficiency of the study group was 92.6%, which was significantly higher than that 78% in the control group. The differences were significant (P0.05).Conclusion The application of aprotinin combined with growth inhibitor in the treatment of severe acute pancreatitis has significant effect, can shorten the recovery time and has high safety and high clinical application value.
展开▼
